Bridget Tarnowski of Glenside ran the New York City Marathon on November 3 to raise funds for 261 Fearless, Inc., a global ...

NEW YORK--(BUSINESS WIRE)--Koneksa ... and Switzerland. Over his 20-year tenure at Merck & Co., Inc., Eric helped to integrate research and commercial strategies in a number of key therapeutic areas ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisor, ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.

Vice President Kamala Harris’ husband, Doug Emhoff, has stayed by her side as she's campaigned for the 2024 presidential ...

Pfizer's non-COVID product revenues surged 14% operationally last quarter. The oncology business delivered exceptional ...

Dow has been struggling to grow for several quarters. Keytruda now makes up close to half of Merck's revenue. As you can see ...

WASHINGTON (AP) — Kamala Harris ' campaign is actively warning business leaders that Donald Trump has a pattern of disregard ...

The drugmaker emphasized plans to move further away from singular reliance on Keytruda while reporting solid sales growth in ...

Merck & Co. lowered the top end of its full-year sales forecast after demand for its HPV vaccine fell for a second straight ...

The global market for pet over-the-counter (OTC) medication is poised for substantial expansion, with an estimated valuation ...

The partners are also studying their personalized vaccine with Keytruda as an adjuvant NSCLC treatment for those who haven't gotten neoadjuvant therapy.